News

GlaxoSmithKline plc (GSK) announced the appointment of Tony Wood as Chief Scientific Officer (CSO) designate. Tony will assume full accountability for Research and Development (R&D)…
Read More...

Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir tablets…
Read More...

Evotec SE announced that the Company has entered into a drug discovery collaboration with Eli Lilly and Company (“Lilly”) in the field of metabolic diseases with a focus on kidney…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with the United Nations Children’s Fund…
Read More...

Kinnate Biopharma Inc. a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers,…
Read More...

Boehringer Ingelheim, a global leader in animal health, and MabGenesis, a private biopharmaceutical company headquartered in Yokohama, Japan, announce that they have entered into a…
Read More...

BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today the dose administration for the first patient in Canada in…
Read More...

On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND)…
Read More...

Abbisko Therapeutics Co., Ltd. announced that it has entered into a worldwide collaboration and exclusive licensing agreement (the "Agreement") with Eli Lilly and Company ("Lilly") for…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has signed an expanded drug discovery collaboration agreement with Neurimmune AG (Zurich, Switzerland; CEO, Roger M Nitsch; “Neurimmune”).…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval for the label extension of KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in a combination…
Read More...

BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for the…
Read More...

ABL Bio, Inc. announced an exclusive collaboration and worldwide license agreement with SANOFI to develop and commercialize ABL301, a pre-clinical stage bispecific antibody targeting…
Read More...

Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, the world’s leading provider of…
Read More...

BigHat Biosciences, Inc., a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced the successful…
Read More...

Adamis Pharmaceuticals Corporation nnounced the submission of a Fast Track Application to the U.S. Food and Drug Administration (FDA) for Tempol for the treatment and prevention of…
Read More...

Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial1 that compared single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs.…
Read More...

Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, announced a strategic collaboration and option…
Read More...

Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced they have…
Read More...